Atlas FDA

COLOGUARD

FDA premarket approval P130017/S062 · decided 2025-03-14

Approval details

PMA number
P130017
Supplement
S062
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
COLOGUARD
Generic name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Applicant
Exact Sciences Corporation
Date received
2025-02-13
Decision date
2025-03-14
Days to decision
29 days
Decision code
OK30
Product code
PHP
Advisory committee
Pathology
Expedited review
No
Location
Medison, WI
Statement
a manufacturing process change and related addition of in-house manufacturing facilities

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.